(Press-News.org) The discovery of a previously unknown molecular target has inspired what may become a therapeutic breakthrough for people with glioblastoma, the most common and aggressive brain cancer.
When people hear the word “cancer” they often picture a single mass, but glioblastoma cells are also highly invasive and spread quickly from the central mass, making it very difficult to fully eradicate. Even with current treatments such as temozolomide, the standard chemotherapy approved to treat glioblastoma, temozolomide-resistant tumours recur in more than 50 per cent of patients with less than one per cent surviving ten years after diagnosis.
In a study published in Nature Cancer, a research team at The Hospital for Sick Children (SickKids) showcased a new potential treatment approach for glioblastoma called a designer peptide, which targets a protein-protein interaction in the glioblastoma cells.
“By uncovering the role of a previously unknown protein-protein interaction in glioblastoma, we were able to develop a designer peptide which possesses robust therapeutic efficacy in treating all major types of glioblastoma in preclinical models,” says Dr. Xi Huang, a Senior Scientist in the Developmental & Stem Cell Biology program. “This could form the basis of next generation glioblastoma therapy.”
Protein-protein interaction holds key to glioblastoma aggression
The development of the designer peptide began when Huang and first author Dr. Weifan Dong discovered that two proteins called EAG2 and Kvβ2, both highly present in glioblastoma cells, were interacting where cancerous cells meet with healthy brain tissue.
“We examined these two proteins closely and found that when they interacted they created a potassium channel complex that is fundamental to the aggressive nature of the cancer,” says Dong, a former PhD student and current post-doctoral fellow in the Huang Lab. “What’s amazing is that this EAG2-Kvβ2 potassium channel complex appears to form only in glioblastoma cells, not healthy cells.”
Excited by their findings, Huang’s team began investigating this specific interaction as a potential target for glioblastoma treatment. They determined that EAG2-Kvβ2 interaction is required for neurons to communicate with glioblastoma cells, facilitating tumour growth, invasion and chemoresistance. The designer peptide prevents the protein-protein interaction from occurring, slowing growth and deterring the cancer from spreading into surrounding cells. In preclinical models, the designer peptide also resulted in the death of glioblastoma cells across all subtypes of glioblastoma.
“Even tumours that had developed resistance to temozolomide responded to the designer peptide,” says Dong. “But we did not observe any side effects, likely due to the EAG2-Kvβ2 interaction only seeming to be present in cancerous cells”.
Building a next-generation treatment
Over the course of the eight-year study the research team garnered important insights and support from leaders across the SickKids community, from Dr. Lu-Yang Wang, Senior Scientist in the Neurosciences & Mental Health program, to Dr. Roman Melnyk, Senior Scientist in the Molecular Medicine program and Co-Director of SPARC Drug Discovery, and Dr. Peter Dirks, Senior Scientist in the Developmental & Stem Cell Biology program.
Now, with the support of Industry Partnerships & Commercialization (IP&C) at SickKids, Huang’s designer peptide discovery has been protected by the filing of a Patent Cooperation Treaty (PCT) application, while active commercialization efforts led by IP&C are underway. Together, the team plans to complete preclinical studies and advance this designer peptide into clinical trials as soon as possible.
“Our study has benefited tremendously from the vibrant research community at SickKids,” says Huang, who also holds Canada Research Chair in Cancer Biophysics. “We are continuing to work closely with other scientists and industry partners to fully unlock the potential of the designer peptide and move our research from the lab into the hands of people who need it most.”
This research was funded by SickKids Foundation, the Canadian Cancer Society, Concern Foundation, b.r.a.i.n.child, Canadian Institutes of Health Research (CIHR), National Sciences and Engineering Research Council (NSERC), Sontag Foundation, Meagan’s HUG, Ontario Institute for Cancer Research, Ontario Ministry of Research, Innovation and Science, Arthur and Sonia Labatt Brain Tumour Research Centre, Garron Family Cancer Centre.
Discovery of protein-protein interaction lays foundation for future glioblastoma therapy
ELSE PRESS RELEASES FROM THIS DATE:
The human lipidome reveals new indicators of health, disease and aging
The sequencing of the human genome promised a revolution in medicine, but scientists soon realized that a genetic blueprint alone does not show the body in action. That required understanding the proteome – all the proteins, expressed by our genes, forming the cellular machinery that performs the bulk of the body’s functions. Now, another set of molecules known as the lipidome – all the lipids in our bodies – is filling in more details of human physiology. Lipids are a broad category of small, fatty or oily molecules, including triglycerides, cholesterol, hormones ...
Auxin signaling pathway controls root hair formation for nitrogen uptake
Plants have evolved diverse adaptive strategies to optimize the exploration of light and soil resources from their environments. One of the most prominent adaptive responses is the developmental plasticity of their root systems, which enables plants to efficiently forage nutrient pools that fluctuate in space and time. As a crucial component determining the active root surface, root hairs represent a powerful morphological trait to improve water and nutrient acquisition. Root hairs are extensions of epidermal cells that effectively enlarge the root surface area and facilitate soil exploration for water and nutrients. Root hair development starts with cell fate specification, which ...
Hobbies linked to lower depression levels among older people
Having a hobby is linked to fewer depressive symptoms and higher levels of happiness, self-reported health and life satisfaction among people aged 65 and over, and this holds true across 16 countries on three continents, according to a new study led by UCL (University College London) researchers. The study, published in the journal Nature Medicine, aimed to see if the benefits of hobbies were consistent in different national settings, and looked at data from 93,263 people aged 65 or over who had enrolled in five existing longitudinal studies in England, Japan, United States, China and 12 European countries. Analysing data from participants spanning four to eight ...
Higher breast cancer risk after certain forms of childhood cancer treatment
Women who have been treated for cancer as a child with a certain type of chemotherapy have an increased risk of breast cancer, according to a large-scale international study of survivors of childhood cancer led by scientists from the Princess Máxima Center for pediatric oncology. The results were published today, 11 September, in the leading journal Nature Medicine and point to the need for earlier breast cancer screening in women who have previously been treated with this chemotherapy and radiation for childhood cancer. Three out of four children with cancer are successfully treated ...
Super antifreeze in cells: The ability to survive in ice and snow developed in animals far earlier than we thought
The globe was hot and humid. The sea was teeming with life. Early squids, eel-like fish and sea worms hunted smaller animals. Above ground, however, nothing stirred. The animals had not yet crawled ashore. That was what the Earth looked like about 450 million years ago at the end of the Ordovicium period. The warm water created the perfect living conditions for wildlife. But this would soon change. Shortly after, the land masses would began to freeze and an ice cap start to spread. The water, which had ...
The important connectivity of metal oxides with hydrogen
Understanding the interactions between materials and chemical species is critical for engineers as it helps them determine their best uses for both day-to-day life and global-level applications. Metal oxides, a binary material of metal and oxygen, greatly interest researchers because of their importance in transforming energy storage, production, and conversion. To further those possibilities, a team from the University of Pittsburgh Swanson School of Engineering has determined a new way to view how hydrogen and metal oxides interact. “Numerous experimental techniques have been used to understand this phenomenon – from spectroscopy to catalysis” explained Giannis ...
ETH Zurich chooses Symplectic Grant Tracker to promote world-class research
Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that ETH Zurich has chosen Symplectic Grant Tracker from Digital Science’s suite of flagship products to power its internal funding program, to promote world-class research with the potential to result in fundamental new knowledge or technologies and exciting discoveries. Designed from the outset to meet research funding needs, Grant Tracker includes features to assist applicants, reviewers, committees and funders and help them to work efficiently and effectively across the grants management lifecycle. The ETH Zurich Research ...
Cancer-causing mutations rewire growth signalling in prostate cancer model
Key points: The PIP3/PI3K signalling pathway is one of the most important signalling mechanisms in our cells, affecting cell metabolism and growth. It is also one of the most frequently altered pathways in human cancer. Research from the Institute has shown that PI3K pathway remodelling is a common feature of cancers driven by hyperactivated PI3K signalling. Working in prostate tumour models the team identified an unknown activator driving PI3K signalling and cancer growth in a way that is released both from needing positive growth signals and also from growth-limiting feedback controls. This knowledge identifies new ...
Study finds probation associated with poorer health for Black Americans
“Mistrust all in whom the impulse to punish is powerful,” warned Friedrich Nietzsche more than a century ago. Instead, the impulse to punish appears to have grown more and more powerful in the U.S criminal justice system. Annually, more than 9 million people a year in the U.S. are arrested, and on any given day roughly 2.3 million are incarcerated, representing a 500% increase in the prison and jail population since 1980 (compared to a 46% increase in the population over the same time). This ...
University of Bath is home to UK’s first pilot plant for recycling plastic lab waste
A company co-founded by a University of Bath graduate has opened the UK’s first pilot plant that can recycle up to 60% of plastic lab waste, to make back into new lab consumables. LabCycle hopes the technology could be scaled up in the future to recycle waste from healthcare, research and commercial labs that is currently incinerated or sent to landfill. To avoid cross-contamination between experiments, most lab-based scientists use a significant amount of single-use plastic in their daily research, including pipette tips, test tubes, petri dishes and multi-well ...